Chronic cerebral hypoperfusion-induced impairment of Aβ clearance requires HB-EGF-dependent sequential activation of HIF1α and MMP9

被引:51
作者
Ashok, Anushruti [1 ,2 ]
Rai, Nagendra Kumar [1 ,2 ]
Raza, Waseem [2 ]
Pandey, Rukmani [1 ,2 ]
Bandyopadhyay, Sanghamitra [1 ,2 ]
机构
[1] Acad Sci & Innovat Res AcSIR, CSIR IITR Campus, Lucknow, Uttar Pradesh, India
[2] CSIR, Indian Inst Toxicol Res, Dev Toxicol Lab, Syst Toxicol & Hlth Risk Assessment Grp, Vishvigyan Bhavan,31,Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India
关键词
BCCAO; HB-EGF; RAGE; LRP-1; BBB; AD; BLOOD-BRAIN-BARRIER; CAROTID-ARTERY OCCLUSION; FACTOR KNOCKOUT MICE; GROWTH-FACTOR; ALZHEIMERS-DISEASE; AMYLOID-BETA; RAT-BRAIN; MATRIX METALLOPROTEINASES; COGNITIVE IMPAIRMENT; RECEPTOR ACTIVATION;
D O I
10.1016/j.nbd.2016.07.013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Chronic cerebral hypoperfusion (CCH) manifests Alzheimer's Disease (AD) neuropathology, marked by increased amyloid beta (A beta). Besides, hypoxia stimulates Heparin-binding EGF-like growth factor (HB-EGF) mRNA expression in the hippocampus. However, involvement of HB-EGF in CCH-induced A beta pathology remains unidentified. Here, using Bilateral Common Carotid Artery Occlusion mouse model, we explored the mechanism of HB-EGF regulated A beta induction in CCH. We found that HB-EGF inhibition suppressed, while exogenous-HB-EGF triggered hippocampal A beta, proving HB-EGF-dependent A beta increase. We also detected that HB-EGF affected the expression of primary A beta transporters, receptor for advanced glycation end-products (RAGE) and lipoprotein receptor-related protein-1 (LRP-1), indicating impaired A beta clearance across the blood-brain barrier (BBB). An HB-EGF-dependent loss in BBB integrity supported impaired A beta clearance. The effect of HB-EGF on Amyloid Precursor Protein pathway was relatively insignificant, suggesting a lesser effect on A beta generation. Delving into BBB disruption mechanism demonstrated HB-EGF-mediated stimulation of Matrix metalloprotease-9 (MMP9), which affected BBB via HB-EGF-ectodomain shedding and epidermal growth factor receptor activation. Examining the intersection of HB-EGF-regulated pathway and hypoxia revealed HB-EGF-dependent increase in transcription factor, Hypoxia-inducible factor-1alpha (HIF1 alpha.). Further, via binding to hypoxia-responsive elements in MMP9 gene, HIFI a stimulated MMP9 expression, and therefore appeared as a prominent intermediary in HB-EGF-induced BBB damage. Overall, our study reveals the essential role of HB-EGF in triggering CCH-mediated A beta accumulation. The proposed mechanism involves an HB-EGF-dependent HIF1 alpha increase, generating MMP9 that stimulates soluble-HB-EGF/EGFR-induced BBB disintegration. Consequently, CCH-mediated hippocampal RAGE and LRP-1 deregulation together with BBB damage impair A beta transport and clearance where HB-EGF plays a pivotal role. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:179 / 193
页数:15
相关论文
共 63 条
[1]  
[Anonymous], 2008, J VIS EXP
[2]   Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy [J].
Asakura, M ;
Kitakaze, M ;
Takashima, S ;
Liao, Y ;
Ishikura, F ;
Yoshinaka, T ;
Ohmoto, H ;
Node, K ;
Yoshino, K ;
Ishiguro, H ;
Asanuma, H ;
Sanada, S ;
Matsumura, Y ;
Takeda, H ;
Beppu, S ;
Tada, M ;
Hori, M ;
Higashiyama, S .
NATURE MEDICINE, 2002, 8 (01) :35-40
[3]   Exposure to As-, Cd-, and Pb-Mixture Induces Aβ, Amyloidogenic APP Processing and Cognitive Impairments via Oxidative Stress-Dependent Neuroinflammation in Young Rats [J].
Ashok, Anushruti ;
Rai, Nagendra Kumar ;
Tripathi, Sachin ;
Bandyopadhyay, Sanghamitra .
TOXICOLOGICAL SCIENCES, 2015, 143 (01) :64-80
[4]   Extracellular Matrix and Matrix Receptors in Blood-Brain Barrier Formation and Stroke [J].
Baeten, Kim M. ;
Akassoglou, Katerina .
DEVELOPMENTAL NEUROBIOLOGY, 2011, 71 (11) :1018-1039
[5]   Interleukin-1α stimulates non-amyloidogenic pathway by α-secretase (ADAM-10 and ADAM-17) cleavage of APP in human astrocytic cells involving p38 MAP kinase [J].
Bandyopadhyay, Sanghamitra ;
Hartley, Dean M. ;
Cahill, Catherine M. ;
Lahiri, Debomay K. ;
Chattopadhyay, Naibedya ;
Rogers, Jack T. .
JOURNAL OF NEUROSCIENCE RESEARCH, 2006, 84 (01) :106-118
[6]   Amyloid Triggers Extensive Cerebral Angiogenesis Causing Blood Brain Barrier Permeability and Hypervascularity in Alzheimer's Disease [J].
Biron, Kaan E. ;
Dickstein, Dara L. ;
Gopaul, Rayshad ;
Jefferies, Wilfred A. .
PLOS ONE, 2011, 6 (08)
[7]   Upregulation of BACE1 and β-Amyloid Protein Mediated by Chronic Cerebral Hypoperfusion Contributes to Cognitive Impairment and Pathogenesis of Alzheimer's Disease [J].
Cai Zhiyou ;
Yan Yong ;
Sun Shanquan ;
Zhang Jun ;
Huang Liangguo ;
Yan Ling ;
Li Jieying .
NEUROCHEMICAL RESEARCH, 2009, 34 (07) :1226-1235
[8]   Matlnspector and beyond: promoter analysis based on transcription factor binding sites [J].
Cartharius, K ;
Frech, K ;
Grote, K ;
Klocke, B ;
Haltmeier, M ;
Klingenhoff, A ;
Frisch, M ;
Bayerlein, M ;
Werner, T .
BIOINFORMATICS, 2005, 21 (13) :2933-2942
[9]   Endophilin-1 regulates blood-brain barrier permeability via EGFR-JNK signaling pathway [J].
Chen, Lin ;
Liu, Wenjing ;
Wang, Ping ;
Xue, Yixue ;
Su, Qingjie ;
Zeng, Chaosheng ;
Shang, Xiuli .
BRAIN RESEARCH, 2015, 1606 :44-53
[10]   Systemic Biomarkers of Neutrophilic Inflammation, Tissue Injury and Repair in COPD Patients with Differing Levels of Disease Severity [J].
Cockayne, Debra A. ;
Cheng, Donavan T. ;
Waschki, Benjamin ;
Sridhar, Sriram ;
Ravindran, Palanikumar ;
Hilton, Holly ;
Kourteva, Galina ;
Bitter, Hans ;
Pillai, Sreekumar G. ;
Visvanathan, Sudha ;
Mueller, Kai-Christian ;
Holz, Olaf ;
Magnussen, Helgo ;
Watz, Henrik ;
Fine, Jay S. .
PLOS ONE, 2012, 7 (06)